Moderna
MRNA
#1188
Rank
$15.15 B
Marketcap
$39.39
Share price
-0.43%
Change (1 day)
-54.30%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Market capitalization of Moderna (MRNA)

Market cap: $15.15 Billion USD

As of December 2024 Moderna has a market cap of $15.15 Billion USD. This makes Moderna the world's 1188th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Moderna from 2018 to 2024

End of year Market Cap

Year Marketcap Change
2024$15.15 B-60.03%
2023$37.91 B-45.05%
2022$69.00 B-32.99%
2021$102.97 B149.1%
2020$41.33 B528.01%
2019$6.58 B31.11%
2018$5.02 B

End of Day market cap according to different sources

On Dec 20th, 2024 the market cap of Moderna was reported to be:

$15.15 Billion USD
by Yahoo Finance info icon info icon
$15.15 Billion USD
by CompaniesMarketCap info icon info icon
$15.15 Billion USD
by Nasdaq info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
$0.10 B-99.31%๐Ÿ‡บ๐Ÿ‡ธ USA
$248.03 B 1,536.31%๐Ÿ‡บ๐Ÿ‡ธ USA
$0.83 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA
$31.65 B 108.85%๐Ÿ‡บ๐Ÿ‡ธ USA
$194.14 B 1,180.84%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
$2.42 B-84.03%๐Ÿ‡บ๐Ÿ‡ธ USA
$347.82 B 2,194.69%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.97 B-80.36%๐Ÿ‡บ๐Ÿ‡ธ USA